Expression of human fibrinogen in transgenic mice

Anuradha Subramanian, Stephen P. Butler, Frank C. Gwazdauskas, Henryk Lubon, William H Velander

Research output: Contribution to conferencePaper

1 Citation (Scopus)

Abstract

Human fibrinogen (hfib) is a 340 kDa plasma protein which is a complex precursor substrate to fibrin during clot formation. The present work evaluates the potential of the mammary gland of transgenic mice to coordinately express three separate cDNAs for hfib and then assemble hexameric, functional recombinant human fibrinogen (rhfib). Trigenic mice were made by pronuclear co-microinjection of separate constructs for each cDNA of the Aα, Bβ and γ hfib polypeptides. Each transgene contained a 2.6 kb promoter sequence from the murine whey acidic protein (mWAP). Trigenic mice expressing rhfib at about 5-35 μg/ml milk were generated. The rhfib showed an apparent molecular weight by SDS-PAGE similar to that of hfib under non-reducing conditions. Under reducing conditions, the α-chain of rhfib had slightly greater mobility than α-chain from hfib. The rhfib was converted to fibrin by thrombin in a manner similar to that of hfib where a normal fibrin clot and a lower apparent mobility of the α-chain from the clot relative to the starting precursor chains were observed for both rhfib and hfib. In summary, these results show that functional fibrinogen can be synthesized and secreted by the mammary gland of transgenic mice.

Original languageEnglish (US)
Pages57-60
Number of pages4
StatePublished - Jan 1 1997
EventProceedings of the 1997 16th Southern Biomedical Engineering Conference - Biloxi, MS, USA
Duration: Apr 4 1997Apr 6 1997

Other

OtherProceedings of the 1997 16th Southern Biomedical Engineering Conference
CityBiloxi, MS, USA
Period4/4/974/6/97

Fingerprint

Proteins
Polypeptides
Molecular weight
Plasmas
Substrates
Milk

ASJC Scopus subject areas

  • Engineering(all)

Cite this

Subramanian, A., Butler, S. P., Gwazdauskas, F. C., Lubon, H., & Velander, W. H. (1997). Expression of human fibrinogen in transgenic mice. 57-60. Paper presented at Proceedings of the 1997 16th Southern Biomedical Engineering Conference, Biloxi, MS, USA, .

Expression of human fibrinogen in transgenic mice. / Subramanian, Anuradha; Butler, Stephen P.; Gwazdauskas, Frank C.; Lubon, Henryk; Velander, William H.

1997. 57-60 Paper presented at Proceedings of the 1997 16th Southern Biomedical Engineering Conference, Biloxi, MS, USA, .

Research output: Contribution to conferencePaper

Subramanian, A, Butler, SP, Gwazdauskas, FC, Lubon, H & Velander, WH 1997, 'Expression of human fibrinogen in transgenic mice' Paper presented at Proceedings of the 1997 16th Southern Biomedical Engineering Conference, Biloxi, MS, USA, 4/4/97 - 4/6/97, pp. 57-60.
Subramanian A, Butler SP, Gwazdauskas FC, Lubon H, Velander WH. Expression of human fibrinogen in transgenic mice. 1997. Paper presented at Proceedings of the 1997 16th Southern Biomedical Engineering Conference, Biloxi, MS, USA, .
Subramanian, Anuradha ; Butler, Stephen P. ; Gwazdauskas, Frank C. ; Lubon, Henryk ; Velander, William H. / Expression of human fibrinogen in transgenic mice. Paper presented at Proceedings of the 1997 16th Southern Biomedical Engineering Conference, Biloxi, MS, USA, .4 p.
@conference{7ac17e379adc4449af914bc3ba106c19,
title = "Expression of human fibrinogen in transgenic mice",
abstract = "Human fibrinogen (hfib) is a 340 kDa plasma protein which is a complex precursor substrate to fibrin during clot formation. The present work evaluates the potential of the mammary gland of transgenic mice to coordinately express three separate cDNAs for hfib and then assemble hexameric, functional recombinant human fibrinogen (rhfib). Trigenic mice were made by pronuclear co-microinjection of separate constructs for each cDNA of the Aα, Bβ and γ hfib polypeptides. Each transgene contained a 2.6 kb promoter sequence from the murine whey acidic protein (mWAP). Trigenic mice expressing rhfib at about 5-35 μg/ml milk were generated. The rhfib showed an apparent molecular weight by SDS-PAGE similar to that of hfib under non-reducing conditions. Under reducing conditions, the α-chain of rhfib had slightly greater mobility than α-chain from hfib. The rhfib was converted to fibrin by thrombin in a manner similar to that of hfib where a normal fibrin clot and a lower apparent mobility of the α-chain from the clot relative to the starting precursor chains were observed for both rhfib and hfib. In summary, these results show that functional fibrinogen can be synthesized and secreted by the mammary gland of transgenic mice.",
author = "Anuradha Subramanian and Butler, {Stephen P.} and Gwazdauskas, {Frank C.} and Henryk Lubon and Velander, {William H}",
year = "1997",
month = "1",
day = "1",
language = "English (US)",
pages = "57--60",
note = "Proceedings of the 1997 16th Southern Biomedical Engineering Conference ; Conference date: 04-04-1997 Through 06-04-1997",

}

TY - CONF

T1 - Expression of human fibrinogen in transgenic mice

AU - Subramanian, Anuradha

AU - Butler, Stephen P.

AU - Gwazdauskas, Frank C.

AU - Lubon, Henryk

AU - Velander, William H

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Human fibrinogen (hfib) is a 340 kDa plasma protein which is a complex precursor substrate to fibrin during clot formation. The present work evaluates the potential of the mammary gland of transgenic mice to coordinately express three separate cDNAs for hfib and then assemble hexameric, functional recombinant human fibrinogen (rhfib). Trigenic mice were made by pronuclear co-microinjection of separate constructs for each cDNA of the Aα, Bβ and γ hfib polypeptides. Each transgene contained a 2.6 kb promoter sequence from the murine whey acidic protein (mWAP). Trigenic mice expressing rhfib at about 5-35 μg/ml milk were generated. The rhfib showed an apparent molecular weight by SDS-PAGE similar to that of hfib under non-reducing conditions. Under reducing conditions, the α-chain of rhfib had slightly greater mobility than α-chain from hfib. The rhfib was converted to fibrin by thrombin in a manner similar to that of hfib where a normal fibrin clot and a lower apparent mobility of the α-chain from the clot relative to the starting precursor chains were observed for both rhfib and hfib. In summary, these results show that functional fibrinogen can be synthesized and secreted by the mammary gland of transgenic mice.

AB - Human fibrinogen (hfib) is a 340 kDa plasma protein which is a complex precursor substrate to fibrin during clot formation. The present work evaluates the potential of the mammary gland of transgenic mice to coordinately express three separate cDNAs for hfib and then assemble hexameric, functional recombinant human fibrinogen (rhfib). Trigenic mice were made by pronuclear co-microinjection of separate constructs for each cDNA of the Aα, Bβ and γ hfib polypeptides. Each transgene contained a 2.6 kb promoter sequence from the murine whey acidic protein (mWAP). Trigenic mice expressing rhfib at about 5-35 μg/ml milk were generated. The rhfib showed an apparent molecular weight by SDS-PAGE similar to that of hfib under non-reducing conditions. Under reducing conditions, the α-chain of rhfib had slightly greater mobility than α-chain from hfib. The rhfib was converted to fibrin by thrombin in a manner similar to that of hfib where a normal fibrin clot and a lower apparent mobility of the α-chain from the clot relative to the starting precursor chains were observed for both rhfib and hfib. In summary, these results show that functional fibrinogen can be synthesized and secreted by the mammary gland of transgenic mice.

UR - http://www.scopus.com/inward/record.url?scp=0030676220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030676220&partnerID=8YFLogxK

M3 - Paper

SP - 57

EP - 60

ER -